Stock research
RPRX Royalty Pharma plc
Healthcare • Medical - Pharmaceuticals
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed...…
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
1Y change
+51.43%
Range high
$59.97
Congress · 90d
0
Insiders · 90d
0
Public signal layer
Who is disclosing activity in RPRX?
Price
Showing 1Y history. Source: FMP historical price full.
- Prev Close
- $58.43
- Day High
- $58.29
- Day Low
- $56.97
- 52w High
- $60.44
- 52w Low
- $34.08
- Volume
- 872,269.00458
- Avg Volume
- Beta
- 0.42
* TTM/most recent where available
Company
- Ticker
- RPRX
- Exchange
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- Country
- US
- CEO
- Pablo Legorreta
- Employees
- 100
- Website
- www.royaltypharma.com
Key Metrics
- Market Cap
- 24.7B
- P/E
- P/B
- P/S
- EV/EBITDA
- ROE
- Net Margin
- Div Yield
- FCF/Share
* TTM/most recent where available
DCF Valuation
Standard DCF
Levered DCF
Market Price
DCF vs Price (30D window)
Price uses last 30 days; DCF line holds latest value across the window.DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).